Substrate
business

Maryland Board Sets $274 Monthly Cap on Ozempic for State Purchases

The Maryland Prescription Drug Affordability Board voted to cap the price of Ozempic at $274 per 30-day supply for state and local government purchases starting January 2027. The limit is expected to save $5.8 million annually and follows a similar action taken by the board in recent weeks.

Stat
1 source·May 18, 10:08 PM(10 days ago)·1m read
Maryland Board Sets $274 Monthly Cap on Ozempic for State Purchasesfoxbusiness.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

The Maryland Prescription Drug Affordability Board agreed to set an upper payment limit for the Ozempic diabetes treatment. The board will oversee a process to lower the cost of the type 2 diabetes medicine for state and local governments by January 2027. At that time the price will be capped at $274 for a 30-day supply. 8 million a year.

The expected cost was benchmarked against the maximum fair price paid by Medicare, said Andrew York, executive director of the Maryland board. The board is expected to begin acting in 2028 to set upper payment limits on high-cost drugs purchased by all Marylanders in the commercial insurance market as well. Nine states have been pursuing the idea of prescription drug affordability boards.

Key Facts

$274 monthly cap
30-day supply price for state and local government purchases
$5.8 million annual savings
estimated yearly reduction in state drug spending
January 2027
date when new price limit takes effect
Andrew York
executive director who confirmed Medicare benchmark

Story Timeline

3 events
  1. May 18, 2026

    Maryland board agreed to cap Ozempic price for state purchases at $274 monthly starting January 2027.

    1 sourceStat
  2. May 2026

    Board took similar step on another drug in recent weeks.

    1 sourceStat
  3. 2028

    Board expected to begin setting limits on drugs for commercial insurance market.

    1 sourceStat

Potential Impact

  1. 01

    State and local governments will pay lower prices for Ozempic starting January 2027.

  2. 02

    The board plans to extend similar price limits to commercial insurance purchases in 2028.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count128 words
PublishedMay 18, 2026, 10:08 PM
Bias signals removed1 across 1 outlet
Signal Breakdown
Framing 1

Related Stories

EU Fines Temu €200 Million Over Unsafe ProductsLos Angeles Times
business2 hrs ago

EU Fines Temu €200 Million Over Unsafe Products

The European Commission imposed a €200 million fine on Chinese e-commerce platform Temu for failing to assess risks from illegal goods. The penalty is the second issued under the Digital Services Act.

Los Angeles Times
The New York Times
BBC News
3 sources
Aggreko to Build Off-Grid Hybrid Plant for Eva Copper MineAbc
business22 hrs ago

Aggreko to Build Off-Grid Hybrid Plant for Eva Copper Mine

Global energy company Aggreko will construct Australia's largest off-grid renewable hybrid power facility at the Eva Copper Mine in North West Queensland. The 15-year project will supply 72 megawatts of power using solar, battery storage and thermal generation.

Abc
1 source
EU fines Temu more than $230 million over illegal product salestheyeshivaworld.com
business1 day ago

EU fines Temu more than $230 million over illegal product sales

The European Commission imposed a €200 million penalty on the Chinese e-commerce platform after finding consumers are very likely to encounter illegal items. Temu has until August 26 to submit a compliance plan or face further penalties.

The New York Times
The Verge
2 sources